OCT Conference 2022 | Booth 29

 Meet Veristat at the Outsourcing in Clinical Trials Europe  2022 ( OCT)   taking place on the  4th -5th  May 2022,  Booth #29

Webinar | Expediting Access to Novel/Medicinal Products in the US and EU

Regulatory Pathways Available to Speed Development and Approval

DIA Conference 2022 | Booth E04

Veristat and SFL, a Veristat company,  attend DIA Europe 2022

Gene Therapy for Rare Disorders 2022 | Booth #22

Meet Veristat at the Gene Therapy for Rare Disorders Conference 2022 in Boston, MA -  March 7-10, 2022 at Booth 22

Webinar on Medical Devices Software

Veristat (formerly DDR) and partner CN Group co-organized an informative session on the development and Regulation of Medical Device Software (MDSW). The live webinar was held on 14 October 2021 and covered the main considerations to keep in mind when...

ACDM Annual Conference 2022 | Booth #17

Meet Veristat at the ACDM Annual Conference  2022 taking place on the  13th -15th  March 2022,  Booth #17

On-Demand Webinar | What is the Future Landscape of Cell and Gene Therapies?

The Potential for New Efficiencies to Allow for Scalability in Cell and Gene Therapy Clinical Development

2021 TOPRA Awards Event

Veristat  To Sponsor the TOPRA Awards 2021 

London - UK 18th November 2021

Orphan Drug Congress Europe |                 Booth #54

Meet Veristat at the Orphan Drug Congress 2021 taking place on 15-18  November 2021,  Booth #54

On-Demand Webinar| Expanding your Clinical Trial into the US - Submit your IND for non-US Sponsors

How, why, and when to expand your clinical trial program into the US, including differences between IND and CTA